key: cord-0930724-1dhl2bx8
authors: Feehan, Jack; de Courten, Maximilian; Apostolopoulos, Vasso; de Courten, Barbora
title: Nutritional Interventions for COVID-19: A Role for Carnosine?
date: 2021-04-26
journal: Nutrients
DOI: 10.3390/nu13051463
sha: 0a8ddd7844d89c6d088a3758db0049dac9bae228
doc_id: 930724
cord_uid: 1dhl2bx8

As COVID-19 continues to take an enormous toll on global health, the effort to find effective preventive and treatment strategies has been unparalleled in recent history [...].

without initiating an excessive inflammatory response. This excessive response, known as a cytokine storm, is central to many of the most damaging and potentially life-threatening consequences of COVID-19 [13] . This cytokine storm is characterized by a significant upregulation of inflammatory cytokines, notably interleukin (IL)-1, IL-6, and tumor necrosis factor alpha, as well as being associated with a high neutrophil to lymphocyte ratio [13] . Carnosine has been demonstrated to ameliorate these markers of immune hyperactivity in models of lipopolysaccharide and bleomycin-induced lung injury [14, 15] , indicating that it may prevent the excessive immune response in patients with COVID-19. This is likely to occur through its anti-inflammatory and anti-oxidant actions [16] , as COVID-19 patients have been shown to be under significant inflammation and oxidative stress, which has been suggested to influence the hyperinflammatory response [17] . The cytokine storm of COVID-19 can also lead to acute respiratory distress syndrome (ARDS). Patients with ARDS due to COVID-19 have a higher mortality rate than those without and are commonly not responsive to ventilation and other supportive treatments [18] . Carnosine has been shown to protect against lung injury associated with ARDS, through its powerful antioxidant effects, reducing reactive oxygen species -mediated toxicity to the lung cells in animal models of lipopolysaccharide-induced pulmonary injury [14] and H9N2 swine influenza [9] . The combined anti-inflammatory and anti-oxidative effects of carnosine make it particularly suited to be considered as supportive treatment in patients with COVID-19. While carnosine supplementation may have a beneficial impact alone, there is also potential for its use alongside other nutritional interventions in patients with COVID-19. Several other nutrients have been investigated for use in patients infected with COVID-19, with potentially synergistic immune effects. Vitamins D, C, and B are all known to be immunomodulatory, and have been suggested to have potential in dampening the aggressive immune response and cytokine storm associated with COVID-19 [3, 4] . Other trace minerals such as zinc and selenium, as well as omega-3 fatty acids, have also been shown to have some benefits which may improve the outcomes of patients with COVID-19, improving outcomes in respiratory infection, which has led many to recommend their use [29] . Interestingly, others have recommended pre-and pro-biotic interventions, as they also improve respiratory symptoms [30] . A "multi-nutrient" intervention, consisting of carnosine, alongside these additional immune-enhancing vitamins and minerals, could be used to enhance patient outcomes.

While research into these potential effects is preliminary, the role of carnosine in patients with COVID-19 is promising and therefore there is a need for trials to test the effi- While the anti-inflammatory and anti-oxidant properties of carnosine are well established, there are some other potential avenues by which it may aid in the treatment of COVID-19. While originally thought to be a primary respiratory pathology, it is now known that COVID-19 is a system-wide disease, leading to multi-organ failure, and cerebrovascular events. This is at least partially due to the increase in coagulation associated with the infection, which leads to microvascular damage, and stroke [19] . It has been proposed that the anti-oxidant and anti-glycating properties of carnosine may provide protection from this hypercoagulability, particularly in patients with altered glucose metabolism, who are known to have increased COVID-19 morbidity and mortality [16, 17] . Others have suggested that carnosine may in fact prevent binding and internalization of SARS-CoV-2, potentially reducing both the incidence and severity of disease [20] . The SARS-CoV-2 spike protein has high binding affinity for angiotensin-converting enzyme 2 (ACE2), using this as a means of attachment and entry to the host cell [21] . In silico modelling of known pharmaceutical and therapeutic compounds revealed that carnosine is also able to bind to ACE2 as an inhibitor, potentially competing with the SARS-CoV-2 spike protein and reducing effective entry to host cells [20] .

A new and concerning development in the management of patients with COVID-19 is the newly understood syndrome of "long COVID" in which symptoms develop and evolve over weeks and months following the infection [22] . Symptoms of long COVID are varied between individuals, but commonly include fatigue, physical pain, reduced exercise tolerance, dyspnea, gastrointestinal symptoms, headaches, memory and concentration difficulties, and psychological disturbance [22, 23] . While research into the underlying cause of long COVID syndrome is in its infancy, it is currently thought to be the result of widespread, chronic multi-system inflammation, secondary to significant inflammatory activation, and cytokine storm [24, 25] . This inflammation is thought to affect the lungs and cardiovascular, central nervous, and gastrointestinal systems [25] [26] [27] , however, many questions remain. As patients with long COVID report significant decreases in quality of life [22] , identifying strategies to manage it are critical. Given its inflammatory and anti-oxidative properties as well as its effects on exercise performance [28] and cardiac and cognitive function [3] , carnosine supplementation could prevent or at least reduce symptoms related to long COVID. In addition, if the cytokine storm due to COVID-19 is rapidly suppressed, it is possible that ongoing symptoms may be decreased, or avoided entirely. Carnosine should therefore be evaluated for use in these patients.

While carnosine supplementation may have a beneficial impact alone, there is also potential for its use alongside other nutritional interventions in patients with COVID-19. Several other nutrients have been investigated for use in patients infected with COVID-19, with potentially synergistic immune effects. Vitamins D, C, and B are all known to be immunomodulatory, and have been suggested to have potential in dampening the aggressive immune response and cytokine storm associated with COVID-19 [3, 4] . Other trace minerals such as zinc and selenium, as well as omega-3 fatty acids, have also been shown to have some benefits which may improve the outcomes of patients with COVID-19, improving outcomes in respiratory infection, which has led many to recommend their use [29] . Interestingly, others have recommended pre-and pro-biotic interventions, as they also improve respiratory symptoms [30] . A "multi-nutrient" intervention, consisting of carnosine, alongside these additional immune-enhancing vitamins and minerals, could be used to enhance patient outcomes.

While research into these potential effects is preliminary, the role of carnosine in patients with COVID-19 is promising and therefore there is a need for trials to test the efficacy of carnosine for prevention, as a supportive measure during the infection as well as in long COVID (Figure 1 ). Given the high tolerability and absence of significant side effects, alongside its anti-inflammatory and an antioxidant effects, it could provide a low-cost, scalable solution for this indication. This is particularly noteworthy given carnosine's well-known benefits in patient demographics who are at increased risk from COVID-19, including the elderly and those living with diabetes.

Author Contributions: J.F., writing-original draft; writing-review and editing; M.d.C., conceptualization; writing-review and editing; B.d.C., conceptualization; writing-review and editing; V.A., conceptualization; supervision; writing-review and editing. All authors have read and agreed to the published version of the manuscript.

Funding: This research received no external funding. and The Greek Orthodox Archdiocese of Australia. J.F. is a recipient of a University of Melbourne PhD scholarship.

The authors declare no conflict of interest.

Is COVID-19 the worst pandemic? Maturitas 2021

COVID-19 Vaccines in the Pipeline, Are Antibodies Adequate? Vaccines

Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: Could they help against COVID-19? Maturitas

Be well: A potential role for vitamin B in COVID-19

The potential of carnosine in brain-related disorders: A comprehensive review of current evidence

Physiological and therapeutic effects of carnosine on cardiometabolic risk and disease

Can the skeletal muscle carnosine response to beta-alanine supplementation be optimized? Front

Understanding the antioxidant and carbonyl sequestering activity of carnosine: Direct and indirect mechanisms

Carnosine markedly ameliorates H9N2 swine influenza virus-induced acute lung injury

L-carnosine modulates respiratory burst and reactive oxygen species production in neutrophil biochemistry and function: May oral dosage form of non-hydrolized dipeptide L-carnosine complement anti-infective anti-influenza flu treatment, prevention and self-care as an alternative to the conventional vaccination?

Management of the virulent influenza virus infection by oral formulation of nonhydrolized carnosine and isopeptide of carnosine attenuating proinflammatory cytokine-induced nitric oxide production

Carnosine exhibits significant antiviral activity against Dengue and Zika virus

The COVID-19 cytokine storm; what we know so far

Preventive Effects of Carnosine on Lipopolysaccharideinduced Lung Injury

Protective effect of orally administered carnosine on bleomycin-induced lung injury

A versatile antioxidant and antiglycating agent

COVID-19 and Oxidative Stress

Pathophysiology of COVID-19-associated acute respiratory distress syndrome: A multicentre prospective observational study

Coagulation abnormalities and thrombosis in patients with COVID-19

Carnosine to Combat Novel Coronavirus (nCoV): Molecular Docking and Modeling to Cocrystallized Host Angiotensin-Converting Enzyme 2 (ACE2) and Viral Spike Protein

Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?

Covid-19: What do we know about "long covid

Long COVID-19-it's not over until?

Cardiovascular complications in COVID-19

Disease (COVID-19), Systemic Inflammation, and Cardiovascular Disease

Neuroimmune correlates of the nervous system involvement of COVID-19: A commentary

He, Y. gastrointestinal features in COVID-19 and the possibility of faecal transmission

Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure

Nutrition, immunity and Covid-19

The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19